TFS
IMPL

TrustCore Financial Services’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

TrustCore Financial Services’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$54K Buy
14,407
+1,000
+7% +$3.65K ﹤0.01% 437
2022
Q3 		$65K Hold
13,407
– – 0.01% 410
2022
Q2 		$125K Hold
13,407
– – 0.01% 316
2022
Q1 		$85K Hold
13,407
– – 0.01% 382
2021
Q4 		$116K Hold
13,407
– – 0.01% 316
2021
Q3 		$163K Buy
+13,407
New +$195K 0.02% 293

Other funds holding IMPL

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TrustCore Financial Services's IMPL Position: Q4 2022 in Review

TrustCore Financial Services increased its Impel Pharmaceuticals Inc. Common Stock (IMPL) stake by 7.5% in Q4 2022, buying an estimated $3.65K and bringing the position to 14,407 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #437.

TrustCore Financial Services first reported a position in IMPL in Q3 2021 and has held it in 6 quarters since. The position peaked at $163K in Q3 2021. 35 funds tracked by Wall St. Rank hold IMPL as of Q4 2022.

  • TrustCore Financial Services held 14,407 shares of Impel Pharmaceuticals Inc. Common Stock worth $54K as of Q4 2022.
  • TrustCore Financial Services bought 1,000 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2022, an estimated $3.65K.
  • Impel Pharmaceuticals Inc. Common Stock made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #437 holding.
  • TrustCore Financial Services first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q3 2021 and has held it in 6 quarters since.
  • TrustCore Financial Services's Impel Pharmaceuticals Inc. Common Stock position peaked at $163K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.